Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

ARVN

Arvinas Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

ARVN:Arvinas Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$15.38

EXCHANGE

NASDAQ

SECTOR

Health Care

ARVN
Arvinas Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
ARVN
Arvinas Inc Stock Information
Latest Close Price$15.38
52-Week Low/High$13.70 - $21.25
Percent Held by Institutions0.00%
Revenue$0
Net Income$0
Cash Flow$0
EPS0.00%
Market Cap$479,625,300
PE Ratio0
PE Ratio to Industry61%
Debt-Equity Ratio1.00%
Debt-Equity to Industry1.39%
Total Return Last 12 Months0.00%
Total Return Last 3 Years0.00%
Total Return Last 5 Years0.00%
Latest Trade DateDec. 17, 2018
ARVN
Arvinas Inc Dividend Payment History

No Data available for Payment History.

ARVN
Arvinas Inc Other Details

Arvinas is a biopharmaceutical company. Through its subsidiaries, Co. is engaged in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Co.'s lead products include ARV-110, proteolysis targeting chimeras (PROTAC) targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer; and ARV-471, a PROTAC targeting the estrogen receptor protein for the treatment of women with metastatic ER+ breast cancer. Co. is also developing other PROTACs for degrading AR and other clinically relevant AR point mutations; and various other products for the treatment of neurodegenerative diseases.

Web Sitewww.arvinas.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Arvinas Inc Dividend Stock News and Updates

Dec. 15, 2018CLOSE PRICE DECREASE: Arvinas Inc (NASDAQ: ARVN) on 12-15-2018 decreased close price > 10% from $15.99 to $14.20

Read more...

Dec. 05, 2018CLOSE PRICE INCREASE: Arvinas Inc (NASDAQ: ARVN) on 12-05-2018 increased close price > 10% from $15.29 to $17.00

Read more...

Nov. 13, 2018CLOSE PRICE DECREASE: Arvinas Inc (NASDAQ: ARVN) on 11-13-2018 decreased close price > 10% from $18.40 to $16.26

Read more...
More Arvinas Inc Dividend News
Pharmaceuticals Dividend Stock News and Updates

Dec. 18, 2018CLOSE PRICE INCREASE: AXM Pharma Inc (OTCBB: AXMP) on 12-18-2018 increased close price > 10% from $0.00 to $0.00

Read more...

Dec. 18, 201852 WEEK LOW: Aceto Corp (NASDAQ: ACET) on 12-18-2018 hit a 52 week low of $1.25

Read more...

Dec. 18, 2018CLOSE PRICE DECREASE: Aceto Corp (NASDAQ: ACET) on 12-18-2018 decreased close price > 10% from $1.39 to $1.25

Read more...
More Pharmaceuticals Dividend News
FREE REPORT
X
Bryan Perry Dividend Income Expert Bryan Perry

Earn 8% on this "Government Mandated Income Opportunity"

X

Search Dividend Investor